Clinical Trial Detail

NCT ID NCT01371630
Title Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphoblastic leukemia

Therapies

Inotuzumab ozogamicin

Cyclophosphamide + Cytarabine + Inotuzumab ozogamicin + Methotrexate + Vincristine Sulfate

Mercaptopurine + Methotrexate + Prednisone + Vincristine Sulfate

Rituximab

Cytarabine + Inotuzumab ozogamicin + Methotrexate

Age Groups: senior adult

No variant requirements are available.